Baird Mandalas Brockstedt & Federico is a full-service law firm providing legal services to individuals, governmental entities, and organizations across the country who have been harmed by corporate and institutional abuse.
BMBF has been at the forefront of some of the most complex and significant civil actions in Delaware, Maryland, and nationally, and has taken a lead role in mass torts and class actions in both state and federal court.
The team spans six offices throughout Delaware and Maryland and includes nearly 30 award-winning attorneys working in more than a dozen practice areas, with an experienced team dedicated to mass torts and class actions.
The attorneys at BMBF are experienced, highly renowned counsel known for taking on corporations and obtaining meaningful results. With a core commitment to Truth, Transparency, and Accountability, the BMBF team is dedicated to fighting for justice and making a real impact in the lives of those we represent.
Helping Governments Hold Wrongdoers Accountable
The mass torts team at BMBF specialize in matters that require special attention, considerable experience, and a high level of sophistication. That specialization has allowed us to develop the ability to offer clients an intense and highly individualized focus on their matters.
We have a proven track record of successfully representing counties, municipalities, school boards, and other governmental authorities, including in litigation involving JUUL, opioids, and social media.
Juul Labs, Inc., Marketing, Sales Practices, and Products Liability Litigation
BMBF represents nearly 60 school boards – including Chicago Public Schools, Wake County Public School System, Prince George’s County Public Schools, Anne Arundel County Public Schools, Prince William County Public Schools, Loudoun County Public Schools, and Horry County Public Schools in multidistrict litigation against JUUL Labs, Inc. and other co-defendants.
This was part of an effort that resulted in a national settlement in excess of $1 billion that was announced in January 2023. As a result of BMBF’s efforts, these school boards will be receiving significant compensation toaddress the vaping epidemic in their districts.
National Prescription Opiate Litigation
BMBF represents more than 40 governmental authorities across the country in their efforts to obtain relief for their communities ravaged by the opioid epidemic. The promotion and marketing of opioid prescription by manufacturers, distributors, and pharmacies contributed to the waves of epidemic opioid addiction now covering the US.
Members of the BMBF team helped lead a consortium of attorneys and law firms representing counties and cities in Florida and South Carolina that have benefited from the nearly $50 billion in settlements reached with the defendants.
Social Media Adolescent Addiction/Personal Injury Products Liability Litigation
BMBF is pursuing claims against social media giants Meta (owner of Facebook and Instagram, Google (owner of YouTube), ByteDance (owner of TikTok), and Snap (owner of Snapchat) for their role in the youth mental health crisis that is harming students and placing an increasingly large burden on school systems to provide adequate and essential mental health resources.
Multi-district litigation (“MDL”) against these companies on behalf of youth and school boards across the country is underway in the United States District Court for the Northern District of California. With our extensive background in representing school boards in litigation against corporate defendants and obtaining meaningful results, we are poised to take on these social media companies on behalf of our clients.
Insulin Pricing Litigation
Despite relatively few technological innovations, the price of insulin in the US has steadily and dramatically increased. In just the last 20 years, the list price of insulin has grown by up to 1000%. As a result, we are now facing an insulin affordability crisis. The companies producing insulin face allegations of engineering price increases on insulin through an opaque, conspiratorial kickback scheme that has exponentially increased their profits at the expense of payors.
Our team aims to help hold these companies accountable for their unjust and exploitative manipulation of insulin prices. At the end of 2023, the lawsuits against insulin manufacturers and PBMs were consolidated into a multi-district litigation (MDL) in the United States District Court of New Jersey (Case 2:23-md-03080-BRM-RLS). With this consolidation, new cases against insulin manufacturers and PBMs can be filed in this court.